These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11092613)

  • 1. Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas.
    Warzocha K; Ribeiro P; Renard N; Bienvenu J; Charlot C; Coiffier B; Salles G
    Cancer Immunol Immunother; 2000 Nov; 49(9):469-75. PubMed ID: 11092613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of two lymphotoxin beta isoforms expressed in human lymphoid cell lines and non-Hodgkin's lymphomas.
    Warzocha K; Renard N; Charlot C; Bienvenu J; Coiffier B; Salles G
    Biochem Biophys Res Commun; 1997 Sep; 238(2):273-6. PubMed ID: 9299492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysis in the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation.
    Reddy J; Chastagner P; Fiette L; Liu X; Thèze J
    Int Immunol; 2001 Feb; 13(2):135-47. PubMed ID: 11157847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualization of lymphotoxin-beta and lymphotoxin-beta receptor expression in mouse embryos.
    Browning JL; French LE
    J Immunol; 2002 May; 168(10):5079-87. PubMed ID: 11994460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo.
    Abe K; Yarovinsky FO; Murakami T; Shakhov AN; Tumanov AV; Ito D; Drutskaya LN; Pfeffer K; Kuprash DV; Komschlies KL; Nedospasov SA
    Blood; 2003 Feb; 101(4):1477-83. PubMed ID: 12560241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF and lymphotoxin beta cooperate in the maintenance of secondary lymphoid tissue microarchitecture but not in the development of lymph nodes.
    Kuprash DV; Alimzhanov MB; Tumanov AV; Anderson AO; Pfeffer K; Nedospasov SA
    J Immunol; 1999 Dec; 163(12):6575-80. PubMed ID: 10586051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor/cachectin and lymphotoxin gene expression in lymph nodes from lymphoma patients.
    Sappino AP; Seelentag W; Pelte MF; Alberto P; Vassalli P
    Blood; 1990 Feb; 75(4):958-62. PubMed ID: 2302463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for tumor necrosis factor receptor type 1 in gut-associated lymphoid tissue development: genetic evidence of synergism with lymphotoxin beta.
    Koni PA; Flavell RA
    J Exp Med; 1998 Jun; 187(12):1977-83. PubMed ID: 9625757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome.
    Warzocha K; Ribeiro P; Bienvenu J; Roy P; Charlot C; Rigal D; Coiffier B; Salles G
    Blood; 1998 May; 91(10):3574-81. PubMed ID: 9572991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A blocks the expression of lymphotoxin alpha, but not lymphotoxin beta, in human peripheral blood mononuclear cells.
    Kuprash DV; Boitchenko VE; Yarovinsky FO; Rice NR; Nordheim A; Rühlmann A; Nedospasov SA
    Blood; 2002 Sep; 100(5):1721-7. PubMed ID: 12176893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
    Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
    J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha-308 and Lymphotoxin alpha+252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt.
    Ibrahim A; Abdel Rahman H; Khorshied M; Sami R; Nasr N; Khorshid O
    Leuk Res; 2012 Jun; 36(6):694-8. PubMed ID: 22177457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells.
    Endres R; Alimzhanov MB; Plitz T; Fütterer A; Kosco-Vilbois MH; Nedospasov SA; Rajewsky K; Pfeffer K
    J Exp Med; 1999 Jan; 189(1):159-68. PubMed ID: 9874572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs.
    Wilhelm P; Riminton DS; Ritter U; Lemckert FA; Scheidig C; Hoek R; Sedgwick JD; Körner H
    Eur J Immunol; 2002 Jul; 32(7):1993-2003. PubMed ID: 12115620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of HLA DRB1 genetic polymorphisms in non-Hodgkin's lymphomas].
    Kalinka E; Juszczyński P; Woszczek G; Borowiec M; Robak T; Kowalski ML; Biliński P; Coiffier B; Salles G; Warzocha K
    Przegl Lek; 2005; 62(12):1422-6. PubMed ID: 16786764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice.
    Alimzhanov MB; Kuprash DV; Kosco-Vilbois MH; Luz A; Turetskaya RL; Tarakhovsky A; Rajewsky K; Nedospasov SA; Pfeffer K
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9302-7. PubMed ID: 9256477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines.
    Phillips TA; Ni J; Hunt JS
    Placenta; 2001; 22(8-9):663-72. PubMed ID: 11597186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression.
    Force WR; Walter BN; Hession C; Tizard R; Kozak CA; Browning JL; Ware CF
    J Immunol; 1995 Dec; 155(11):5280-8. PubMed ID: 7594541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function.
    Wang J; Foster A; Chin R; Yu P; Sun Y; Wang Y; Pfeffer K; Fu YX
    Eur J Immunol; 2002 Jul; 32(7):1969-79. PubMed ID: 12115617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.